Definition Tumour markers are chemical substances that are produced by some cancers. Most of these substances can be found in the bloodstream in small amounts even when cancer is not present. When cancers produce these substances, they are usually produced in very large amounts. The amount of the substances may increase far above a normal level as the disease worsens.
What is the information for this topic? Not all cancers produce tumour markers. Having a high level of a marker does not always mean that a cancer is present. Because of this, tumour markers are not usually used to diagnose cancer. Instead, tumour markers are often used to monitor cancer after it has been diagnosed. It is also used to monitor the treatment of certain types of cancer. The most common tumour markers and the type of cancer they signal include:
AFP/BCG, for testicular cancer in men and certain types of cancers of the reproductive system in women
CEA. This marker may be elevated in some bowel cancers and certain other cancers. CEA levels are used to monitor people who are being treated for bowel cancer. It is not used to identify people who are thought to have bowel cancer. This is because many bowel cancers do not produce abnormally high levels of CEA in the early stages.
CA-125. This is a tumour marker for ovarian cancer and occasionally cancer of the uterus. It is useful to have this test done when cancer is suspected. However, this test is not always reliable. Some women with ovarian cancer may not have high levels of CA-125. High levels are common in women with advanced ovarian cancer.
This tumour marker is also used to see how the body is responding to treatment. If the level of CA-125 in the blood goes down after treatment, the disease is probably responding. If the level goes up, the disease may be getting worse.
PSA. Prostate-specific antigen (PSA) is a substance that is normally produced by the prostate gland in small amounts. Men with prostate cancer may produce large amounts of this substance. The PSA level can also be slightly high in a man whose prostate gland is enlarged for reasons other than cancer. A higher-than-normal PSA level does not always indicate cancer. A normal level of PSA does not always mean that prostate cancer is not present. PSA alone is not a completely reliable tool for detecting prostate cancer in healthy men. However, when combined with a physical examination of the prostate, PSA can detect prostate cancer early. For men who have prostate cancer, PSA levels can help in seeing how the disease is responding to treatment.
AFP/BCG (alpha fetoprotein and beta chorionic gonadotropin). These two substances are normally produced by pregnant women. People with certain cancers can have extremely high levels of one or both of these markers, such as:
women with certain types of cancers of the reproductive organs
some liver cancers
Not all cancers of these types produce these markers. If the cancer does produce one or both of these substances, monitoring their level can be helpful in seeing how the disease is responding to treatment. The level of the markers will drop as the cancer is treated.
In general, tumour markers are helpful to monitor the course of a cancer. The levels can show if a particular treatment is working or if the cancer is getting worse. Tumour markers are not always reliable enough to be used to detect cancer early on.
Author: Miriam P. Rogers, EdD, RN, AOCN, CNS Reviewer: eknowhow Medical Review Panel Editor: Dr John Hearne
Last Updated: 7/03/2005 Contributors Potential conflict of interest information for reviewers available on request
This website and article is not a substitute for independent professional advice. Nothing contained in this website is intended to be used as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professional's advice. All Health and any associated parties do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information.
